S Mengo

Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.

Giulio Cerea, Massimo Vaghi, A Ardizzoia et al. · PubMed · 2003 · 96 citations

Medicine, Oncology, Pharmacology +16

Pretreatment serum markers and lymphocyte response to interleukin-2 therapy

Luca Fumagalli, Paolo Lissoni, G. Di Felice et al. · British Journal of Cancer · 1999 · 49 citations · Full text

Pharmacy, Immunology, Oncology +17

A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.

P. Lissoni, Massimo Vaghi, A Ardizzoia et al. · PubMed · 2003 · 29 citations

Medicine, Oncology, Pharmacology +17

Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.

P. Lissoni, Veronica Bordin, Massimo Vaghi et al. · PubMed · 2002 · 21 citations

Medicine, Immunology, Oncology +12

Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients.

Paolo Lissoni, Fabio Malugani, Roberta Bukovec et al. · PubMed · 2003 · 14 citations

Medicine, Oncology, Pharmacology +17